当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第6期
编号:13004984
间充质干细胞治疗实验性自身免疫性脑脊髓膜炎的研究进展(4)
http://www.100md.com 2017年2月25日 《中国医药导报》 2017年第6期
     [20] Benameur L,Charif N,Li YE,et al. Toward an understanding of mechanism of aging-induced oxidative stress in human mesenchymal stem cells [J]. Biomed Mater Eng,2015,25(1):S41-S46.

    [21] Kemp K,Hares K,Mallam E,et al. Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronalsurviva [J]. Neurochem,2010,114(6):1569-1580.

    [22] Abi Chahine N,Wehbe T,Rashed J,et al. autologous bone marrow derived stem cells for the treatment of multiple sclerosis [J]. Int J Stem Cells,2016,9(2):207-212.

    [23] Wang D,Li SP,Fu JS,et al. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis [J]. Int J Dev Neurosci,2016 ,49:60-66. [24] Makar TK,Bever CT,Singh IS,et al. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle [J]. J Neuroimmunol,2009,210(1/2):40-51.

    [25] Zhang YJ,Zhang W,Lin CG,et al. Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats [J]. J Neurol Sci,2012,313(1/2):64-74.

    (收稿日期:2016-11-03 本文編辑:苏 畅), http://www.100md.com(项正兵 曾红 屈新辉 吴晓牧)
上一页1 2 3 4